Bluejay Diagnostics, Inc. (BJDX): Total Liabilities

Annual figures by period end, from SEC filings.

$1.14M
As of 2025-12-31
$2.12M
As of 2026-06-30
-16.7%
3-year compound annual growth
-9.1%
5-year compound annual growth
$1.98M2020-12-31: $1.85M2021-12-31: $637.2K2022-12-31: $1.98M2023-12-31: $1.97M2024-12-31: $927.9K2025-12-31: $1.14M$1.14M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.14M+23.3%2026-03-06, Balance as of period end
2024-12-31$927.9K-53.0%2026-03-06, Balance as of period end
2023-12-31$1.97M-0.3%2025-03-31, Balance as of period end
2022-12-31$1.98M+210.8%2024-03-28, Balance as of period end
2021-12-31$637.2K-65.5%2023-03-20, Balance as of period end
2020-12-31$1.85Mn/a2022-03-10, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Bluejay Diagnostics, Inc. (BJDX)2025-12-31$1.14M+23.3%
Medinotec Inc. (MDNC)2026-02-28$1.10M-56.6%
Autonomix Medical, Inc. (AMIX)2026-03-31$1.71M-0.1%
Glucotrack, Inc. (GCTK)2025-12-31$5.01M-73.5%
Biotricity Inc. (BTCY)2026-03-31$39.41M+10.5%
Aethlon Medical Inc (AEMD)2026-03-31$1.45M-35.3%
RenovoRx, Inc. (RNXT)2025-12-31$2.67M-26.6%
HeartBeam, Inc. (BEATW)2025-12-31$3.24M+99.8%
Sintx Technologies, Inc. (SINT)2025-12-31$6.58M+19.2%

Compare BJDX, MDNC, AMIX, GCTK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗